OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
Biologics by McKesson was selected as a specialty pharmacy provider for OJJAARA, an oral treatment for adults with myelofibrosis and anemia.